Status:
UNKNOWN
Mindfulness-based Intervention for Postnatal Depression
Lead Sponsor:
The University of Hong Kong
Conditions:
Postnatal Depression
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
Postnatal psychopathology have adverse impact on both mothers and infants. Few postnatal women with depressive symptoms receive treatment, and pharmacological intervention has not been well accepted d...
Eligibility Criteria
Inclusion
- Females aged from 18 and above
- The Edinburgh Postnatal Depression Scale cut-off score of \>=9
- At least 6 weeks, and up to one and half years after childbirth
- Cantonese-speaking Chinese
Exclusion
- Severe physical illness (myocardial infarction, hypertension, fracture, spinal problems in which yoga may be contraindicated), and seizure disorders.
- Comorbid substance dependence
- Women with psychotic depression, severe eating disorders, actively suicidal or obsessive-compulsive disorders
- Known pregnancy
- A history of bipolar disorder, schizophrenia, brain trauma or organic brain disease, mental retardation, or antisocial personality disorder
- Practice of mindfulness (in forms of Tai Chi, Qi gong or yoga etc.) more than twice a week during the previous three months.
Key Trial Info
Start Date :
September 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2021
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT04332146
Start Date
September 1 2019
End Date
September 1 2021
Last Update
April 2 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Queen Mary Hospital
Hong Kong, Hong Kong